Skip to main content
Caplight Logo









Evariste

Evariste

Private
LondonAI, Data & Cloud Infrastructurehttps://www.evariste.com/

Company Overview

Evariste is a biotechnology company that uses mathematics and artificial intelligence to develop small molecule therapeutics for oncology.

Sector

AI, Data & Cloud Infrastructure

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

AI drug discoverysmall molecule therapeuticssynthetic lethalitydrug discovery platformTechBiooncology drug discoverycomputational drug discoverypharma partnershipstarget identificationdrug candidate licensingAI biotechbiomarker discoveryin-silico drug discoveryPKMYT1 inhibitorVRK1 inhibitor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evariste Comparables

Compare Evariste with similar companies based on industry and business-model similarity.

Evariste comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aqemia
87%
Iktos
85%
Genesis Therapeutics
84%

Evariste Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors grew 62% MoM, reaching 1.8K.

  • Dec 9, 2025

    Monthly visitors grew 168% MoM.

Evariste Filings

Explore SEC and related filing metadata, where available.

Evariste filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Evariste's valuation, stock price, and market status.

Is Evariste a public or private company?

Evariste is a private company.

What is the current stock price of Evariste?

Evariste is a private company with no public stock price. Caplight tracks Evariste's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Evariste worth (valuation)?

Valuation information for Evariste is not publicly available.

Can I buy Evariste stock?

Evariste shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Evariste's last funding round?

Funding round information for Evariste is not publicly available.

Who are the main investors in Evariste?

Investor information for Evariste is not publicly disclosed.

Will Evariste IPO soon?

No public IPO plans have been announced for Evariste.

How can I track Evariste secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evariste's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range6
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?